← Back to DCF

Breakdown · JNJ

Johnson & Johnson

WACC
FCF PROJECTION
SENSITIVITY
PER-YEAR CASH FLOWS
Year CF Discount factor PV Cumulative PV
1 7.81 0.9399 7.34 7.34
2 8.12 0.8835 7.17 14.52
3 8.44 0.8304 7.01 21.53
4 8.78 0.7806 6.85 28.38
5 9.13 0.7337 6.70 35.07
6 9.49 0.6896 6.54 41.62
7 9.86 0.6482 6.39 48.01
8 10.26 0.6093 6.25 54.26
9 10.66 0.5727 6.11 60.37
10 11.09 0.5383 5.97 66.33
11 11.36 0.5060 5.75 72.08
12 11.65 0.4756 5.54 77.62
13 11.94 0.4470 5.34 82.96
14 12.24 0.4202 5.14 88.10
15 12.54 0.3950 4.95 93.06
16 12.86 0.3712 4.77 97.83
17 13.18 0.3489 4.60 102.43
18 13.51 0.3280 4.43 106.86
19 13.84 0.3083 4.27 111.13
20 14.19 0.2898 4.11 115.24
REVERSE DCF

At $232.77, the market implies a stage-1 growth rate of 13.9%.

MARKET IMPLIES
13.9%
YOUR ASSUMPTION
4.0%
DELTA
+9.9pp

If $232.77 is correct and your other inputs (WACC 6.4%, 10+10y, terminal 2.5%) hold, the market needs JNJ to grow cash flow at 13.9% annually for the next 10 years.